Shaare Zedek Medical Center
About Shaare Zedek Medical Center
The Shaare Zedek Medical Center is a major hospital in Jerusalem established in 1902.
There are 1,000 beds in Shaare Zedek Medical Center.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Shaare Zedek Medical Center
92
Pfizer
18
Celgene
17
Hoffmann-La Roche
14
Shire
14
Takeda
13
Janssen Research & Development, LLC
11
Eli Lilly and Company
10
Gilead Sciences
8
Boehringer Ingelheim
7
Merck Sharp & Dohme LLC
6
Clinical Trials at Shaare Zedek Medical Center
During the past decade, Shaare Zedek Medical Center conducted 244 clinical trials. In the 10-year time frame, 244 clinical trials started and 81 clinical trials were completed, i.e. on
average, 33.2% percent of trials that started reached the finish line to date. In the past 5 years, 94 clinical trials started and 55 clinical trials were completed. i.e. 58.5%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease
1998-10-01
2002-09-01
Completed
82
Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
1999-08-01
2003-05-01
Completed
Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children
2004-11-01
2006-05-01
Completed
6,635
Pentoxifylline in the Treatment of NEC in Premature Neonates
2005-01-01
2010-03-01
Unknown status
50
Comparison of Delta-8-THC to Ondansetron in the Prevention of Acute Nausea From Moderately Emetogenic Chemotherapy
2005-11-01
2009-02-01
Terminated
6
Fluency Stent-Graft Versus Luminex Stent for Angioplasty of Recurrent Stenosis of the Cephalic Arch in Autogenous Arteriovenous (AV) Access for Hemodialysis
2006-05-01
2006-08-01
Completed
50
to Assess the Efficacy and Safety of the Probiotic E. Coli Strain M17 on Patients With GERD
2006-05-01
2007-05-01
Completed
60
The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill Patients
2007-02-01
2015-09-01
Completed
39
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Shaare Zedek Medical Center" #1 sponsor was "Shaare Zedek Medical Center" with 92 trials, followed by "Pfizer" with 18 trials
sponsored, "Celgene" with 17 trials sponsored, "Hoffmann-La Roche" with 14 trials sponsored and "Shire"
with 14 trials sponsored. Other sponsors include 254 different institutions and
companies that sponsored additional 161 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Shaare Zedek Medical Center"
#1 collaborator was "Shaare Zedek Medical Center" with 10 trials as a collaborator, "Takeda Development Center Americas, Inc." with 5 trials as a collaborator, "AstraZeneca" with 4 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator and "Eli Lilly and Company" with 4 trials as a collaborator. Other collaborators include 144 different institutions and companies that were
collaborators in the rest 127 trials.
Clinical Trials Conditions at Shaare Zedek Medical Center
According to Clinical.Site data, the most researched conditions in "Shaare Zedek Medical Center" are
"Ulcerative Colitis" (28 trials), "Crohn's Disease" (26 trials), "Gaucher Disease" (15 trials), "Breast Cancer" (8 trials) and "Crohn Disease" (8 trials). Many other conditions were trialed in "Shaare Zedek Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Shaare Zedek Medical Center
Most popular intervention types in "Shaare Zedek Medical Center" are "Drug" (269 trials), "Device" (57 trials), "Other" (43 trials), "Biological" (32 trials) and "Procedure" (27 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (78 trials), "placebo" (7 trials), "Carboplatin" (6 trials), "Lenalidomide" (6 trials) and "Pembrolizumab" (6 trials). Other intervention names were less common.
Clinical Trials Genders at Shaare Zedek Medical Center
The vast majority of trials in "Shaare Zedek Medical Center" are
378 trials for "All" genders, 33 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at Shaare Zedek Medical Center
Currently, there are 149 active trials in "Shaare Zedek Medical Center".
4 are not yet recruiting,
86 are recruiting,
57 are Active, not recruiting,
and 2 are Enrolling by invitation.
In total, there were 171 completed trials in Shaare Zedek Medical Center,
4 suspended trials,
and 37 terminated clinical trials to date.
Out of the total trials that were conducted in Shaare Zedek Medical Center, 27 "Phase 1"
clinical trials were conducted, 105 "Phase 2" clinical
trials and 155 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 23 trials, and there were
also 64 trials that are defined as “Not Applicable".
Departments of Shaare Zedek Medical Center
Shaare Zedek Medical Center has several departments that took part in Clinical trials: "Shaare Zedek Medical Center; Oncology Dept" - 12 trials, "Digestive Diseases Institute, Shaare Zedek Medical Center" - 6 trials, "Dept. of Orthopedic Surgery, Shaare Zedek Medical Center" - 4 trials, "Neonatal Intensive Care Unit - Shaare Zedek Medical Center" - 3 trials, "Intensive Care Unit, Shaare Zedek Medical Center" - 2 trials, "Shaare Zedek Medical Center - Gastroenterology" - 2 trials, "The Center for Integrative Complementary Medicine, Shaare Zedek Medical Center" - 2 trials, "The Department of Pediatric Urology, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University" - 2 trials, "Shaare Zedek Medical Center; Pulmonary Inst." - 2 trials, "The Juliet Keidan Institute of Paediatric Gastroenterology and Nutrition; Shaare Zedek Medical Center" - 2 trials
Departments List
Name
City
Trials